alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               SEP-30-1995
<CASH>                                          10,500
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                     27,800
<CURRENT-ASSETS>                                59,900
<PP&E>                                         701,500
<DEPRECIATION>                                (260,700)
<TOTAL-ASSETS>                                 530,700
<CURRENT-LIABILITIES>                           36,200
<BONDS>                                              0
<COMMON>                                         1,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                      1,800
<OTHER-SE>                                     303,600
<TOTAL-LIABILITY-AND-EQUITY>                   530,700
<SALES>                                         73,100
<TOTAL-REVENUES>                                73,100
<CGS>                                           58,100
<TOTAL-COSTS>                                   79,700
<OTHER-EXPENSES>                                 4,800
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               4,000<F1>
<INCOME-PRETAX>                                (15,400)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (15,400)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (15,400)
<EPS-PRIMARY>                                     (.25)
<EPS-DILUTED>                                        0
<FN>
<F1>Net of interest income and other of $2,200
</FN>
        

</TABLE>
[Federal Register Volume 75, Number 45 (Tuesday, March 9, 2010)]
[Notices]
[Page 10823]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4917]


=======================================================================
-----------------------------------------------------------------------

NATIONAL FOUNDATION FOR THE ARTS AND THE HUMANITIES

National Endowment for the Arts


National Council on the Arts 169th Meeting

    Pursuant to section 10(a)(2) of the Federal Advisory Committee Act 
(Pub. L. 92-463), as amended, notice is hereby given that a meeting of 
the National Council on the Arts will be held on March 25-26, 2010 in 
Rooms 716 and M-09 at the Nancy Hanks Center, 1100 Pennsylvania Avenue, 
NW., Washington, DC 20506.
    This meeting, from 5 p.m. to 5:30 p.m. on Thursday, March 25th in 
Room 716 and from 9 a.m. to 10:45 a.m. on Friday, March 26th in Room M-
09 (ending time is approximate), will be open to the public on a space 
available basis. The Thursday agenda will include review and voting on 
applications and guidelines. On Friday, the meeting will begin with 
opening remarks by the Chairman, including a tribute to former NEA Folk 
Arts Director Bess Lomax Hawes, swearing-in of new Council member Irvin 
Mayfield, and Congressional/White House/Budget updates. This will be 
followed by a presentation on Survey of Public Participation in the 
Arts by Sunil Iyengar. The meeting will adjourn following concluding 
remarks.
    If, in the course of the open session discussion, it becomes 
necessary for the Council to discuss non-public commercial or financial 
information of intrinsic value, the Council will go into closed session 
pursuant to subsection (c)(4) of the Government in the Sunshine Act, 5 
U.S.C. 552b, and in accordance with the determination of the Chairman 
of November 10, 2009. Additionally, discussion concerning purely 
personal information about individuals, submitted with grant 
applications, such as personal biographical and salary data or medical 
information, may be conducted by the Council in closed session in 
accordance with subsection (c)(6) of 5 U.S.C. 552b.
    Any interested persons may attend, as observers, Council 
discussions and reviews that are open to the public. If you need 
special accommodations due to a disability, please contact the Office 
of AccessAbility, National Endowment for the Arts, 1100 Pennsylvania 
Avenue, NW., Washington, DC 20506, 202/682-5532, TTY-TDD 202/682-5429, 
at least seven (7) days prior to the meeting.
    Further information with reference to this meeting can be obtained 
from the Office of Communications, National Endowment for the Arts, 
Washington, DC 20506, at 202/682-5570.

    Dated: March 4, 2010.
Kathy Plowitz-Worden,
Panel Coordinator, Office of Guidelines and Panel Operations.
[FR Doc. 2010-4917 Filed 3-8-10; 8:45 am]
BILLING CODE 7537-01-P
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.2280 Cultured animal and human cells. ( a ) *Identification.* Cultured animal and human cells are in vitro cultivated cell lines from the tissue of humans or other animals which are used in various diagnostic procedures, particularly diagnostic virology and cytogenetic studies.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 864.9.
[45 FR 60585, Sept. 12, 1980, as amended at 65 FR 2310, Jan. 14, 2000]
Editorial Note on Part 872
Editorial Note: Nomenclature changes to part 872 appear at 73 FR 35341, June 23, 2008.

§ 872.3540 OTC denture cushion or pad. ( a ) *Identification.* An OTC denture cushion or pad is a prefabricated or noncustom made disposable device that is intended to improve the fit of a loose or uncomfortable denture, and may be available for purchase over-the-counter.
( b ) *Classification.* ( 1 ) Class I if the device is made of wax-impregnated cotton cloth that the patient applies to the base or inner surface of a denture before inserting the denture into the mouth. The device is intended to be discarded following 1 day's use. The class I device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 872.9.
( 2 ) Class II (special controls) if the OTC denture cushion or pad is made of a material other than wax-impregnated cotton cloth or if the intended use of the device differs from that described in paragraph (b)(1) of this section. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 872.9. The special controls for this device are FDA's: ( i ) “Use of International Standard ISO 10993 ‘Biological Evaluation of Medical—Devices Part I: Evaluation and Testing,’ ” and
( ii ) “OTC Denture Reliners, Repair Kits, and Partially Fabricated Denture Kits.”
[52 FR 30097, Aug. 12, 1987, as amended at 65 FR 2315, 2000; 65 FR 17144, Mar. 31, 2000; 84 FR 71812, Dec. 30, 2019]
EXHIBIT 10.4


                                 PROMISSORY NOTE

$83,000.00                        Dallas, Texas                   August 3, 1998

         FOR VALUE  RECEIVED,  Preferred  Voice,  Inc.,  a Delaware  corporation
promises to pay to the order of Capital Growth Fund Ltd., at P.O. Box 3444, Road
Town,  Tortola,  British Virgin Islands,  or at such other address as the holder
hereof  may  designate,  the  principal  sum of Eighty  Three  Thousand  Dollars
($83,000.00),  together with interest on the unpaid  principal  balance from the
date hereof until this note is paid in full at a rate of 10% per annum.

         Principal and interest shall be payable in one installment on August 3,
1999.

         All payments  received shall be applied first to the payment of accrued
interest and then to the payment of principal.

         Maker shall have the right to prepay any and all amounts due  hereunder
without penalty for the privilege of doing so.

         No payment shall be considered in default  unless it is not paid within
ten (10) days after delivery of written notice of nonpayment.

         Holder will have the right at any time to convert this note into shares
of common stock,  $.001 par value per share, of Maker, at the conversion rate of
one share of common  stock for each $.50 of  principal  and  interest due on the
note on the date of conversion.

         In the event  default is made in the  payment of this Note,  the unpaid
balance on this Note shall at once become due and payable,  without  notice,  at
the option of the Holder. Failure to exercise this option shall not constitute a
waiver of the right to declare the entire  principal  due and payable at once at
any subsequent time.

         If, after default,  this Note is placed in the hands of an attorney for
collection,  or if collected  through judicial  proceeding,  Maker shall pay, in
addition to the sums  referred to above,  a reasonable  sum as a  collection  or
attorneys'  fee and all other  costs  incurred  by Holder in  collection  of the
unpaid amounts due hereunder.

         Each maker, surety,  guarantor,  endorser or other party liable for the
payment of this Note, in whole or in part,  hereby expressly waives  presentment
and demand for payment,  notice of intention to accelerate  maturity,  notice of
acceleration of maturity, protest and notice of protest and nonpayment, bringing
of suit and  diligence  in taking any action to collect sums owing  hereon,  and
agree that this Note,  and any payment  hereunder,  may be extended from time to
time without in any way affecting such liability.

MAKER:

Preferred Voice, Inc.


-------------------------
G. Ray Miller
Its: President
United States Court of Appeals FOR THE EIGHTH CIRCUIT

_____________ No. 96-3528

_____________ James M. McGaffin, III, and * Deborah McGaffin, * * Appellant, * * v. * On Appeal from the * United States Tax Court. * Commissioner of Internal * Revenue, * * Appellee. *

___________ Submitted: April 14, 1997 Filed: April 22, 1997

___________ Before RICHARD S. ARNOLD, Chief Judge, FAGG and MURPHY, Circuit Judges.

___________ RICHARD S. ARNOLD, Chief Judge.
Under the Internal Revenue Code, ministers and other members of the cler gycan receive an exemption from self-employment tax if they ar e con scientiouslyopposed to the tax and if they file a request for th e exemption, called a F orm 4361, by a certain specified time. The question presented in this case is whether the taxpayers, the Reverend and Mrs . James McGaffin, III, appellants in

### James M. McGaffin, III , T.C. Memo. 1996-290 (June 24, 1996) 1 

### (John F. Dean, Special Trial Judge). -2- this Court, made a timely filing of t heir Form 4361. The Tax Court found 1 against them, and they appeal.
We affi rm. The question whether the form was filed on time is a question of fact. Th e taxpayers had the burden of proof. After a trial, the T ax Court found that the form was not mailed on time. Mr. McGaffi n testifi edthat it was mailed on time, on April l5, 1986, along with hi s income-tax return for the year 1985. The records of the Internal Revenue Service, on the other hand, show that the income-tax return was no t receiveduntil June 9, 1986. There is no record of the Form 4361's ever being received. The Tax Court was convinced tha t the Form 4361 was mailed along with the income-tax return, crediting Mr. McGaffin’s testimony t o this ex tent, but it was not convinced that the form and the return wer e mailed o n April 15, 1986, which was the deadline for the filing of th e form.
The f inding of the Tax Court is not clearly erroneous. It was no t required to believe all of Mr. McGaffin’s testim ony. As the trier of fact with both live and do cumentary evidence before it, it was open to the Tax Court to conclude tha t the taxpayer’s memory was faulty. The judgment is
Affirmed. A true copy.
Attest: CLERK, U.S. COURT OF APPEALS, EIGHTH CIRCUIT.
# C_2014129EN.01003501.xml

| 28.4.2014 | EN | Official Journal of the European Union | C 129/35 |
| --- | --- | --- | --- |

28.4.2014

EN

Official Journal of the European Union

C 129/35

---

Action brought on 3 March 2014 — adidas v OHIM — Shoe Branding Europe (Device of two parallel stripes)

(Case T-145/14)

(2014/C 129/42)

Language in which the application was lodged: English

Parties

Applicant: adidas (Herzogenaurach, Germany) (represented by: V. von Bomhard and J. Fuhrmann, lawyers)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Other party to the proceedings before the Board of Appeal: Shoe Branding Europe BVBA (Oudenaarde, Belgium)

Form of order sought

The applicant claims that the Court should:

| — | Annul the decision of the Second Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 28 November 2013 given in Case R 1208/2012-2; |
| --- | --- |

—

Annul the decision of the Second Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 28 November 2013 given in Case R 1208/2012-2;

| — | Order the defendant to pay the costs of proceedings. |
| --- | --- |

—

Order the defendant to pay the costs of proceedings.

Pleas in law and main arguments

Applicant for a Community trade mark: The other party to the proceedings before the Board of Appeal

Community trade mark concerned: The mark (‘other type of mark’) for footwear in Class 25 — Community trade mark application No 8 398 141

Proprietor of the mark or sign cited in the opposition proceedings: The applicant

Mark or sign cited in opposition: Community trade mark registrations Nos 3 517 646, 3 517 612, 3 517 588, 3 517 661, 4 269 072, 6 081 889; German trade mark registrations Nos 944 624, 944 623, 399 50 559, 897 134; International trade mark registration No 391 692 for goods in Classes 18, 25 and 28; and non-registered mark/sign used in the course of trade in Germany

Decision of the Opposition Division: Rejected the opposition

Decision of the Board of Appeal: Dismissed the appeal

Pleas in law: Infringement of Articles 8(1)(b) and 8(4) CTMR.

---
# C_2016098EN.01003801.xml

| 14.3.2016 | EN | Official Journal of the European Union | C 98/38 |
| --- | --- | --- | --- |

14.3.2016

EN

Official Journal of the European Union

C 98/38

---

Judgment of the General Court of 28 January 2016 — Arbuzov v Council

(Case T-434/14) (1)

1

((Common foreign and security policy - Restrictive measures adopted in view of the situation in Ukraine - Freezing of funds - List of persons, entities and bodies covered by the freezing of funds and economic resources - Inclusion of the applicant’s name - Proof that inclusion on the list is justified))

(2016/C 098/49)

Language of the case: Czech

Parties

Parties

Applicant: Sergej Arbuzov (Kiev, Ukraine) (represented by: M. Machytková and P. Radošovský, lawyers)

Applicant:

Defendant: Council of the European Union (represented by: A. Westerhof Löfflerová and J.-P. Hix, acting as Agents)

Defendant:

Re:

Re:

Application for annulment of Council Decision 2014/119/CFSP of 5 March 2014 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Ukraine (OJ 2014 L 66, p. 26) and of Council Implementing Decision 2014/216/CFSP of 14 April 2014 implementing Decision 2014/119 (OJ 2014 L 111, p. 91), in so far as the applicant’s name was included on the list of persons, entities and bodies covered by those restrictive measures.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Annuls Council Decision 2014/119/CFSP of 5 March 2014 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Ukraine, as amended by Council Implementing Decision 2014/216/CFSP of 14 April 2014 implementing Decision 2014/119 in so far as it applies to Mr Sergej Arbuzov; |
| --- | --- |

1.

Annuls Council Decision 2014/119/CFSP of 5 March 2014 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Ukraine, as amended by Council Implementing Decision 2014/216/CFSP of 14 April 2014 implementing Decision 2014/119 in so far as it applies to Mr Sergej Arbuzov;

| 2. | Orders the Council of the European Union to bear its own costs and to pay those incurred by Mr Arbuzov. |
| --- | --- |

2.

Orders the Council of the European Union to bear its own costs and to pay those incurred by Mr Arbuzov.

---

(1)  OJ C 282, 26.8.2014.

1

---
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.3145 Coxsackievirus serological reagents. ( a ) *Identification.* Coxsackievirus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to coxsackievirus in serum. Additionally, some of these reagents consist of coxsackievirus antisera conjugated with a fluorescent dye that are used to identify coxsackievirus from clinical specimens or from tissue culture isolates derived from clinical specimens. The identification aids in the diagnosis of coxsackievirus infections and provides epidemiological information on diseases caused by these viruses. Coxsackieviruses produce a variety of infections, including common colds, meningitis (inflammation of brain and spinal cord membranes), herpangina (brief fever accompanied by ulcerated lesions of the throat), and myopericarditis (inflammation of heart tissue).
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 866.9.
[47 FR 50823, Nov. 9, 1982, as amended at 65 FR 2311, Jan. 14, 2000]
U.S. Department of Education

Historically Black Colleges and Universities Master’s Degree Program

Annual Performance Report

FY 2014 Academic Year 2012-2013

1. PR/Award #: _______________________________________

2. Name of Grantee: 

__________________________________________________________________________________________________

3. Grantee Address: 

__________________________________________________________________________________________________

4. Name of Project Director/Contact Person:_______________________________________________________________

 Phone: ( ) ________ - __________ Ext: ( ) Fax: ( ) ________ - __________ 

 Email Address: __________________________________________________

5. Name of Certifying Official:__________________________________________________________________________

 Phone: ( ) ________ - __________ Ext: ( ) Fax: ( ) ________ - __________ 

 Email Address: __________________________________________________

6. Reporting Period: From: _____/_____/_______ To: _____/_____/_______ 

 (Month/Day/Year) (Month/Day/Year)

To the best of our knowledge and belief, all data in this performance report are true and correct and the report fully discloses all known 

weaknesses concerning the accuracy, reliability, and completeness of the data.

Name of Project Director (Print): ____________________________________________________________

Signature: _____________________________________________________ Date: _____/_____/_______

Name of Certifying Official (Print): ___________________________________________________________

Signature: _____________________________________________________ Date: _____/_____/_______

OMB No. 1840-0813

Exp. 

According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it

displays a valid OMB control number. The valid OMB control number for this information collection is 1840-0813. The time 

required to complete this information collection is estimated to average 35 hours per response, including the time to review

instructions, search existing data sources, gather the data needed, and complete and review the information collection. If you 

have any comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please 

write to: U.S. Department of Education, Washington, DC 20202-4651. If you have comments or concerns regarding the 

status of your individual submission of the form, write directly to: Frederick Winter, HBCU Master’s Degree Program, 

U.S. Department of Education, 1990 K Street, N.W., Suite 6153, Washington, DC 20006-8544.
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.3380 Ethosuximide test system. ( a ) *Identification.* An ethosuximide test system is a device intended to measure ethosuximide, an antiepileptic drug, in human specimens. Measurements obtained by this device are used in the diagnosis and treatment of ethosuximide overdose and in monitoring levels of ethosuximide to ensure appropriate therapy.
( b ) *Classification.* Class II.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                      11,490,041
<SECURITIES>                                50,890,907
<RECEIVABLES>                               10,796,643
<ALLOWANCES>                                         0
<INVENTORY>                                 10,099,533
<CURRENT-ASSETS>                            85,925,520
<PP&E>                                       1,139,137
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              88,771,884
<CURRENT-LIABILITIES>                        7,463,529
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       192,766
<OTHER-SE>                                  81,115,589
<TOTAL-LIABILITY-AND-EQUITY>                88,771,884
<SALES>                                     19,394,936
<TOTAL-REVENUES>                            19,394,936
<CGS>                                        6,245,203
<TOTAL-COSTS>                               12,088,627
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              1,771,493
<INCOME-TAX>                                   450,000
<INCOME-CONTINUING>                          1,321,493
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,321,493
<EPS-PRIMARY>                                      .07
<EPS-DILUTED>                                      .07
        

</TABLE>